Published for more than 70 years, the Food and Drug Law Journal is a peer-reviewed quarterly devoted to the scholarly analysis of legislation, regulations, court decisions, and public policies affecting the development, manufacture, marketing, and use of foods, drugs, biologics, cosmetics, medical devices, and tobacco.
Since 2015 the Journal is published in partnership with the Georgetown University Law Center and the O’Neill Institute for National & Global Health Law.
The latest issue of the Food and Drug Law Journal has just been released.
Issue 71:2 of the Food and Drug Law Journal features articles presented at our second annual symposium, Constitutional Challenges to FDA Law and Regulation, held at Georgetown University Law Center last fall. Topics included First Amendment and preemption jurisprudence. Here is a sample article, by Nathan A. Brown and Eli Tomar of Akin Gump, on drug compounding as a case study for the preemptive scope of FDA’s jurisdiction in traditionally state-regulated areas.
Read Full Article
$299 Member | $379 Non-Member
Volume 71, Number 2 Table of Contents
201 Remarks of the FDA Commissioner: The Food and Drug Law Institute’s 59th Annual Conference
Robert M. Califf
Manuscripts presented at the 2nd Annual Food and Drug Law Journal Symposium:
CONSTITUTIONAL CHALLENGES TO FDA LAW AND REGULATION
October 31, 2015, Georgetown University Law Center
Tracing FTC’s Line on Commercial Speech: What Makes an Ad an Ad and Why Does It Matter?
The Benefits of Regulatory Friction in Shaping Policy
Diana R.H. Winters
Preemption of Non-Federal Restraints on Off-Label Product Communications
Jeffrey Chasnow and Geoffrey Levitt
Could State Regulations be the Next Frontier in Preemption Jurisprudence? Drug Compounding as a Case Study
Nathan A. Brown and Eli Tomar
The Scope of Preemption under the 2009 Family Smoking Prevention and Tobacco Control Act
Sam F. Halabi
Access archives of the Journal online
Write for the Food and Drug Law Journal
The Food and Drug Law Journal
- Clarifies the complex regulation and legislation affecting the food, drug, cosmetic, medical device, and healthcare technology industries.
- Explores the possible future implications of proposed regulations and policy trends.
- Analyzes critical court decisions in food and drug law, including intellectual property, antitrust, constitutional and criminal law issues related to the health law field.
- Looks beyond our borders to assess how food- and drug-related issues are regulated in other countries.
- Provides a neutral forum for intelligent discussion and debate among authors from private industry, government agencies, and academic institutions.